酸盐受体1限制了造血,并防止了急性髓性白血病的进展
Vincent Cuminetti1,2,3, Emeline Boet4, Marcel Heugel1,2
1Stem Cells, Ageing and Cancer Research Group, Centre for Embryology and Healthy Development, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
低酸盐受体1 (Sucnr1) 表达表明急性髓性白血病 (AML) 的生存率不佳. Sucnr1信号限制了造血干细胞和原始细胞 (HSPC),其失调有助于AML恶性病变.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 酸盐受体1 (Sucnr1) 涉及炎症,但其在血液形成中的作用在很大程度上尚未被探索.
- 低SUCNR1表达与急性髓性白血病 (AML) 患者的生存率降低相关.
研究的目的:
- 研究Sucnr1在血液形成中的作用及其对AML的影响.
- 阐明Sucnr1通过哪些机制影响造血干细胞和原生细胞 (HSPC).
主要方法:
- 使用了白血病前骨髓形成,AML和AML异种移植的小鼠模型.
- 在体内进行Sucnr1.1的全球和血液构造缺失.
- 使用单细胞RNA测序来重新分析AML异种移植.
主要成果:
- 酸在低SUCNR1.1的模型中促进AML的进展.
- 删除sucnr1导致HSPC扩张和血液形成的改变.
- Sucnr1激活通过S100a8/S100a9调节来保护HSPC的转录程序.
- 塔斯基尼莫德 (S100a9抑制剂) 和Sucnr1激动剂在AML模型中显示出治疗潜力.
结论:
- Sucnr1信号限制了血液形成,部分通过HSPC和S100a8/S100a9.9.
- Sucnr1失调是AML恶性病的原因之一.
- 向Sucnr1为AML患者提供了潜在的治疗策略.
更多相关视频
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Hematopoiesis
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Prevention
Some...
